Future viral vectors for the delivery of asymptomatic herpes epitope-based immunotherapeutic vaccines.
作者信息
Chentoufi Aziz Alami, BenMohamed Lbachir
机构信息
Laboratory of Cellular & Molecular Immunology, The Gavin Herbert Eye Institute, University of California, Irvine, College of Medicine, Irvine, CA 92697-4375, USA.
出版信息
Future Virol. 2010 Sep 1;5(5):525-528. doi: 10.2217/fvl.10.44.
Abstract
摘要
相似文献
1
Future viral vectors for the delivery of asymptomatic herpes epitope-based immunotherapeutic vaccines.
Future Virol. 2010 Sep 1;5(5):525-528. doi: 10.2217/fvl.10.44.
2
The challenges and opportunities for the development of a T-cell epitope-based herpes simplex vaccine.
Vaccine. 2014 Nov 28;32(50):6733-45. doi: 10.1016/j.vaccine.2014.10.002. Epub 2014 Oct 16.
3
Immunogenicity in mice of tandem repeats of an epitope from herpes simplex gD protein when expressed by recombinant adenovirus vectors.
Vaccine. 1993 Sep;11(12):1191-8. doi: 10.1016/0264-410x(93)90042-v.
4
Towards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknown.
Clin Dev Immunol. 2012;2012:187585. doi: 10.1155/2012/187585. Epub 2012 Mar 26.
5
Unique Type I Interferon, Expansion/Survival Cytokines, and JAK/STAT Gene Signatures of Multifunctional Herpes Simplex Virus-Specific Effector Memory CD8 T Cells Are Associated with Asymptomatic Herpes in Humans.
J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.01882-18. Print 2019 Feb 15.
6
Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
J Virol. 2015 Jul;89(13):6619-32. doi: 10.1128/JVI.00788-15.
7
Asymptomatic memory CD8+ T cells: from development and regulation to consideration for human vaccines and immunotherapeutics.
Hum Vaccin Immunother. 2014;10(4):945-63. doi: 10.4161/hv.27762. Epub 2014 Feb 5.
8
Combinatorial Herpes Simplex Vaccine Strategies: From Bedside to Bench and Back.
Front Immunol. 2022 Apr 25;13:849515. doi: 10.3389/fimmu.2022.849515. eCollection 2022.
9
A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens.
J Virol. 2015 Aug;89(16):8497-509. doi: 10.1128/JVI.01089-15. Epub 2015 Jun 3.
10
Future of an "Asymptomatic" T-cell Epitope-Based Therapeutic Herpes Simplex Vaccine.
Future Virol. 2012 Apr 1;7(4):371-378. doi: 10.2217/fvl.12.22.
引用本文的文献
1
Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions.
Vaccines (Basel). 2024 Nov 28;12(12):1345. doi: 10.3390/vaccines12121345.
2
Immunogenicity and Therapeutic Efficacy of a Sendai-Virus-Vectored HSV-2 Vaccine in Mouse and Guinea Pig Models.
Vaccines (Basel). 2023 Nov 24;11(12):1752. doi: 10.3390/vaccines11121752.
3
Combinatorial Herpes Simplex Vaccine Strategies: From Bedside to Bench and Back.
Front Immunol. 2022 Apr 25;13:849515. doi: 10.3389/fimmu.2022.849515. eCollection 2022.
4
Blockade of LAG-3 Immune Checkpoint Combined With Therapeutic Vaccination Restore the Function of Tissue-Resident Anti-viral CD8 T Cells and Protect Against Recurrent Ocular Herpes Simplex Infection and Disease.
Front Immunol. 2018 Dec 17;9:2922. doi: 10.3389/fimmu.2018.02922. eCollection 2018.
5
Unique Type I Interferon, Expansion/Survival Cytokines, and JAK/STAT Gene Signatures of Multifunctional Herpes Simplex Virus-Specific Effector Memory CD8 T Cells Are Associated with Asymptomatic Herpes in Humans.
J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.01882-18. Print 2019 Feb 15.
6
Phenotypic and Functional Signatures of Herpes Simplex Virus-Specific Effector Memory CD73CD45RACCR7CD8 T and CD73CD45RACCR7CD8 T Cells Are Associated with Asymptomatic Ocular Herpes.
J Immunol. 2018 Oct 15;201(8):2315-2330. doi: 10.4049/jimmunol.1800725. Epub 2018 Sep 10.
7
Human Asymptomatic Epitope Peptide/CXCL10-Based Prime/Pull Vaccine Induces Herpes Simplex Virus-Specific Gamma Interferon-Positive CD107 CD8 T Cells That Infiltrate the Corneas and Trigeminal Ganglia of Humanized HLA Transgenic Rabbits and Protect against Ocular Herpes Challenge.
J Virol. 2018 Jul 31;92(16). doi: 10.1128/JVI.00535-18. Print 2018 Aug 15.
8
Bolstering the Number and Function of HSV-1-Specific CD8 Effector Memory T Cells and Tissue-Resident Memory T Cells in Latently Infected Trigeminal Ganglia Reduces Recurrent Ocular Herpes Infection and Disease.
J Immunol. 2017 Jul 1;199(1):186-203. doi: 10.4049/jimmunol.1700145. Epub 2017 May 24.
9
The Herpes Simplex Virus Latency-Associated Transcript Gene Is Associated with a Broader Repertoire of Virus-Specific Exhausted CD8+ T Cells Retained within the Trigeminal Ganglia of Latently Infected HLA Transgenic Rabbits.
J Virol. 2016 Mar 28;90(8):3913-3928. doi: 10.1128/JVI.02450-15. Print 2016 Apr.
10
A Herpes Simplex Virus Type 1 Human Asymptomatic CD8+ T-Cell Epitopes-Based Vaccine Protects Against Ocular Herpes in a "Humanized" HLA Transgenic Rabbit Model.
Invest Ophthalmol Vis Sci. 2015 Jun;56(6):4013-28. doi: 10.1167/iovs.15-17074.
本文引用的文献
1
Viruses as vaccine vectors for infectious diseases and cancer.
Nat Rev Microbiol. 2010 Jan;8(1):62-73. doi: 10.1038/nrmicro2240.
2
Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs.
J Infect Dis. 2009 Oct 1;200(7):1088-95. doi: 10.1086/605645.
3
Progress and prospects: biological properties and technological advances of herpes simplex virus type 1-based amplicon vectors.
Gene Ther. 2009 Jun;16(6):709-15. doi: 10.1038/gt.2009.42. Epub 2009 Apr 16.
4
Herpes simplex virus type 1 thymidine kinase sequence fused to the lacz gene increases levels of {beta}-galactosidase activity per genome of high-capacity but not first-generation adenoviral vectors in vitro and in vivo.
J Virol. 2009 Feb;83(4):2004-10. doi: 10.1128/JVI.01298-08. Epub 2008 Dec 10.
5
Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM.
Mol Ther. 2009 Jan;17(1):199-207. doi: 10.1038/mt.2008.228. Epub 2008 Oct 28.
6
Herpes vector-mediated gene transfer in the treatment of chronic pain.
Mol Ther. 2009 Jan;17(1):13-8. doi: 10.1038/mt.2008.213. Epub 2008 Oct 7.
7
Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virus.
Virology. 2007 Jan 20;357(2):199-214. doi: 10.1016/j.virol.2006.08.007. Epub 2006 Sep 7.
8
HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.
Gene Ther. 2007 Jan;14(1):93-8. doi: 10.1038/sj.gt.3302805. Epub 2006 Aug 24.
9
In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara.
Exp Hematol. 2006 Apr;34(4):497-507. doi: 10.1016/j.exphem.2005.12.018.
10
Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas.
Cancer Gene Ther. 2006 Jun;13(6):539-54. doi: 10.1038/sj.cgt.7700930.
Zotero 插件